| Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer (NCT00525135) | University of California, San Francisco | 2007-08-01 |
| PET/CT: Role in Detecting Unknown Primary Head and Neck Cancer (NCT00656760) | University of Calgary | 2007-07-01 |
| Insomnia in Patients Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer (NCT00616590) | Vanderbilt University | 2007-07-01 |
| Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract (NCT00765440) | Centre Antoine Lacassagne | 2007-07-01 |
| A Study of Intensity-modulated Radiotherapy in Patients With Squamous Cell Carcinoma of Unknown Primary (SCCUP) of the Head and Neck (NCT02112344) | Royal Marsden NHS Foundation Trust | 2007-07-01 |
| BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors (NCT00526149) | European Organisation for Research and Treatment of Cancer - EORTC | 2007-07-01 |
| Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy (NCT00490061) | Quynh-Thu Le | 2007-07-01 |
| A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer (NCT00490282) | M.D. Anderson Cancer Center | 2007-06-01 |
| Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer (NCT00591149) | University of Kansas Medical Center | 2007-06-01 |
| Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer (NCT00896675) | Vanderbilt-Ingram Cancer Center | 2007-06-01 |
| PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy (NCT00809016) | Centre Oscar Lambret | 2007-05-01 |
| Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract (NCT00524017) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-05-01 |
| Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx (NCT00498953) | European Organisation for Research and Treatment of Cancer - EORTC | 2007-05-01 |
| Investigation of Pain and Symptom Burden in Patients With Newly Diagnosed Head and Neck Cancer (NCT00655005) | Vanderbilt-Ingram Cancer Center | 2007-05-01 |
| A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen (NCT00623831) | Ludwig Institute for Cancer Research | 2007-05-01 |
| Pain in Cancer Survivors (NCT00581724) | Memorial Sloan Kettering Cancer Center | 2007-05-01 |
| A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors (NCT00465725) | Poniard Pharmaceuticals | 2007-04-01 |
| Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer (NCT00898742) | Vanderbilt-Ingram Cancer Center | 2007-04-01 |
| Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients (NCT00437372) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2007-03-01 |
| Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors (NCT00620295) | Masonic Cancer Center, University of Minnesota | 2007-03-01 |
| Standard Follow-up Program (SFP) for Head and Neck Cancer Patients (NCT02435576) | University Medical Center Groningen | 2007-03-01 |
| Oral Cancer Screening Among Nursing Home Dentists in Ohio (NCT00526851) | Case Comprehensive Cancer Center | 2007-03-01 |
| Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors (NCT00667641) | University of Medicine and Dentistry of New Jersey | 2007-03-01 |
| Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer (NCT00448240) | Henry Ford Health System | 2007-02-01 |
| Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery (NCT00473564) | University of Alabama at Birmingham | 2007-02-01 |
| A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy (NCT00608751) | Washington University School of Medicine | 2007-01-01 |
| Neck Surgery in Treating Patients With Early-Stage Oral Cancer (NCT00571883) | The Facial Surgery Research Foundation | 2007-01-01 |
| Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer (NCT00485485) | M.D. Anderson Cancer Center | 2007-01-01 |
| MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck (NCT00427102) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-01-01 |
| Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment (NCT00409331) | M.D. Anderson Cancer Center | 2006-12-01 |
| Pilot Study of (61)CuATSM-PET Imaging in Cancer Patients (NCT00585117) | University of Wisconsin, Madison | 2006-12-01 |
| Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer (NCT00401401) | Genmab | 2006-12-01 |
| Pilot Study of 18F-FLT PET (NCT00585741) | University of Wisconsin, Madison | 2006-12-01 |
| Open Label, Phase I ZD6474 Head and Neck Cancer Study (NCT00450138) | Sanofi | 2006-12-01 |
| Treatment of Head & Neck Cancer With Chemotherapy and Radiation (NCT00392704) | SCRI Development Innovations, LLC | 2006-12-01 |
| Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer (NCT00405405) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2006-12-01 |
| Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer (NCT00503997) | Vanderbilt-Ingram Cancer Center | 2006-12-01 |
| PET/CT to Image Hypoxia in Head and Neck Tumours (NCT00395109) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2006-11-08 |
| Effect of an Oral Supplement on the Total Energy and Protein Intake of Head and Neck Cancer Patients in the Last 2 Weeks of Radiation Therapy (NCT00375700) | AHS Cancer Control Alberta | 2006-11-01 |
| Evaluating Taste and Smell Function and Food and Taste Preferences of Head and Neck Cancer Patients During Radiation Therapy/Chemotherapy (NCT00375921) | AHS Cancer Control Alberta | 2006-11-01 |
| OraTest in Combination With Visual Examination and Visual Examination Alone (NCT00537199) | M.D. Anderson Cancer Center | 2006-11-01 |
| Nutritional Status and Barriers to Dietary Intake in Head and Neck Cancer Patients (NCT00375180) | AHS Cancer Control Alberta | 2006-11-01 |
| High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer (NCT00415233) | University College, London | 2006-11-01 |
| Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer (NCT00625937) | Yonsei University | 2006-11-01 |
| Zalutumumab in Patients With Non-curable Head and Neck Cancer (NCT00382031) | Genmab | 2006-11-01 |
| Immunoreactivity to Cetuximab in Cancer Patients (NCT00896896) | Vanderbilt-Ingram Cancer Center | 2006-11-01 |
| A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer (NCT00412217) | Hoffmann-La Roche | 2006-11-01 |
| Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer (NCT01254591) | University College London (UCL) Cancer Institute | 2006-11-01 |
| Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer (NCT00423930) | Memorial Sloan Kettering Cancer Center | 2006-10-01 |
| A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC) (NCT00589667) | Memorial Sloan Kettering Cancer Center | 2006-09-01 |
| Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer (NCT00971867) | Bristol-Myers Squibb | 2006-08-04 |
| Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer (NCT00360971) | Radiation Therapy Oncology Group | 2006-07-01 |
| Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer (NCT00468169) | University of Chicago | 2006-07-01 |
| Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery (NCT00357617) | Centre Hospitalier Universitaire Vaudois | 2006-06-01 |
| DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer (NCT00898664) | Vanderbilt-Ingram Cancer Center | 2006-06-01 |
| The Effect of Norepinephrine and Dopamine on Radial Forearm Free Flap Tissue Oxygen Pressure and Microdialysate Metabolite Measurements (NCT02241083) | Tampere University Hospital | 2006-06-01 |
| Swallow Exercise as Prophylaxis of Dysphagia After Radiotherapy (NCT00332865) | University of Aarhus | 2006-06-01 |
| Prospective Trial of Serial CT Imaging for Evaluation of Dosimetric/Volumetric Changes During IMRT for Head/Neck Cancer (NCT02003482) | University of Miami | 2006-05-09 |
| S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer (NCT00337129) | National Cancer Institute (NCI) | 2006-05-01 |
| INEC Study: Immuno-modulating Enteral Nutrition in Cancer (NCT00333099) | University Hospital, Clermont-Ferrand | 2006-05-01 |
| AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer (NCT00415298) | University of California, San Diego | 2006-05-01 |
| Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx (NCT00899340) | Vanderbilt-Ingram Cancer Center | 2006-05-01 |
| Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer (NCT00387530) | University of California, San Diego | 2006-05-01 |
| The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer (NCT00605488) | Memorial Sloan Kettering Cancer Center | 2006-04-25 |
| DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the Oropharynx (NCT00897988) | Vanderbilt University Medical Center | 2006-04-01 |
| Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer (NCT00301028) | M.D. Anderson Cancer Center | 2006-04-01 |
| S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer (NCT00336947) | Yokohama City University | 2006-04-01 |
| Iodine I 131 in Treating Patients With Thyroid Cancer (NCT00416949) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-04-01 |
| COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma (NCT00603759) | Tehran University of Medical Sciences | 2006-04-01 |
| Cross-Sectional Study of Oral Health in Patients After Parotid-Sparing Radiation Therapy for Head and Neck Cancer (NCT01663246) | University of Michigan Rogel Cancer Center | 2006-04-01 |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer (NCT00352118) | Masonic Cancer Center, University of Minnesota | 2006-03-01 |
| Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer (NCT00291707) | University of Pittsburgh | 2006-03-01 |
| Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection (NCT00508170) | M.D. Anderson Cancer Center | 2006-03-01 |
| Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab (NCT00319839) | University of California, Irvine | 2006-03-01 |
| An Exploratory Study on Optical Assessment of Oral Mucositis (NCT00488332) | M.D. Anderson Cancer Center | 2006-03-01 |
| Nutrition and Resistance Training in Head and Neck Cancer (NCT00696553) | Vanderbilt University | 2006-03-01 |
| Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy (NCT00442520) | University of Kansas Medical Center | 2006-02-01 |
| Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy (NCT00486304) | UNC Lineberger Comprehensive Cancer Center | 2006-02-01 |
| Pre-treatment Exercises Versus Post-treatment Exercises for Dysphagia (NCT00584129) | University of Alabama at Birmingham | 2006-02-01 |
| Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer (NCT00623129) | Mayo Clinic | 2006-02-01 |
| Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking (NCT00365508) | Fox Chase Cancer Center | 2006-02-01 |
| Dynamic Contrast Enhanced MRI (DCE-MRI) Diffusion Weighted MRI (DW-MRI) and Magnetic Resonance Spectroscopy (MRS) of Head and Neck Tumors (NCT00581906) | Memorial Sloan Kettering Cancer Center | 2006-02-01 |
| PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy (NCT00388024) | Wake Forest University Health Sciences | 2006-02-01 |
| Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck Cancer (NCT00293579) | Ohio State University Comprehensive Cancer Center | 2006-02-01 |
| Bupropion in Helping Adults Stop Smoking (NCT00534001) | Roswell Park Cancer Institute | 2006-01-01 |
| Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer (NCT00272181) | Sesen Bio, Inc. | 2006-01-01 |
| Review of Palliative Radiotherapy in the Management of Advanced Head and Neck Cancer (NCT00280891) | Alberta Health services | 2006-01-01 |
| Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer (NCT00412776) | Sesen Bio, Inc. | 2005-12-01 |
| S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx (NCT00268372) | SWOG Cancer Research Network | 2005-12-01 |
| Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer (NCT00176241) | Susanne Arnold | 2005-12-01 |
| A Pilot Study to Evaluate the Feasibility of Combining Submandibular Salivary Gland Tx & IMRT Tomo to Reduce Xerostomia (NCT00497406) | AHS Cancer Control Alberta | 2005-12-01 |
| Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors (NCT00622674) | Masonic Cancer Center, University of Minnesota | 2005-11-01 |
| Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer (NCT00265941) | Radiation Therapy Oncology Group | 2005-11-01 |
| Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer (NCT00245349) | University of Iowa | 2005-10-01 |
| Late Phase II Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Head and Neck Cancer (NCT00855764) | Bristol-Myers Squibb | 2005-10-01 |
| A Trial of Homeopathic Medication TRAUMEEL S for the Treatment of Radiation-Induced Mucositis (NCT00584597) | University of Oklahoma | 2005-10-01 |
| Vaccine Therapy in Treating Patients With Head and Neck Cancer (NCT00404339) | Robert Ferris | 2005-09-01 |
| Endoscopic Surgery or Radiation Therapy in Treating Patients With Stage 0, Stage I, or Stage II Laryngeal Cancer of the Glottis (NCT00334997) | University College London Hospitals | 2005-09-01 |
| Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer (NCT00281840) | Case Comprehensive Cancer Center | 2005-09-01 |
| Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer (NCT00527982) | M.D. Anderson Cancer Center | 2005-09-01 |